NAPL Napo Pharm.Regs

RNS Number:0822R
Napo Pharmaceuticals Inc
31 March 2008


For immediate release                                 31 March 2008

                 Napo Pharmaceuticals, Inc ("Napo" or "the Company")

                       Total Voting Rights and Share Capital



In conformity with the Transparency Directive, Napo Pharmaceuticals, Inc.
("Napo") is required to notify the market of the following:



Napo has issued 600,000 common shares during this month and therefore Napo's
current issued share capital (exclusive of shares held in treasury) now consists
of 53,698,769 common shares with a nominal value of USD $.0001 each, with voting
rights.



Napo Pharmaceuticals, Inc. holds 125,614 common shares in Treasury.



Therefore, the total number of voting rights in Napo (exclusive of shares held
in treasury) is 53,698,769.



The above figure of 53,698,769 common shares may be used by shareholders as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, Napo
under the Financial Service Authority's Disclosure and Transparency Rules.


Name of contact and telephone number for inquiries:

Charles Thompson, Napo Pharmaceuticals, Inc. Company Secretary: 650-616-1903
Napo Pharmaceuticals, Inc
Tel: 650-616-1900
1170 Veterans Boulevard, Suite 244
Fax: 650-873-8367
South San Francisco, CA 94080
USA
Delaware corporation number 3457397





                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

TVRILFVRVAITFIT

Napo Pharm.Regs (LSE:NAPL)
Historical Stock Chart
From Oct 2024 to Nov 2024

Napo Pharm.Regs (LSE:NAPL)
Historical Stock Chart
From Nov 2023 to Nov 2024